StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3027
This month
41
This week
8
This year
209
Yesterday
1
Publishing Date
2023 - 12 - 18
10
2023 - 12 - 13
8
2023 - 12 - 12
11
2023 - 12 - 11
13
2023 - 11 - 03
10
2023 - 11 - 02
8
2023 - 10 - 30
8
2023 - 10 - 16
10
2023 - 09 - 26
10
2023 - 09 - 07
8
2023 - 07 - 17
12
2023 - 06 - 05
13
2023 - 05 - 25
10
2023 - 05 - 16
11
2023 - 05 - 09
8
2023 - 04 - 26
10
2023 - 04 - 17
8
2023 - 03 - 28
8
2023 - 02 - 16
8
2022 - 11 - 03
9
2022 - 09 - 16
9
2022 - 07 - 28
8
2022 - 06 - 22
9
2022 - 06 - 10
9
2022 - 05 - 23
8
2022 - 02 - 25
9
2022 - 02 - 14
9
2021 - 12 - 13
19
2021 - 12 - 09
16
2021 - 12 - 06
8
2021 - 11 - 30
8
2021 - 11 - 29
12
2021 - 11 - 15
9
2021 - 11 - 12
12
2021 - 11 - 09
7
2021 - 11 - 08
8
2021 - 10 - 25
8
2021 - 10 - 15
9
2021 - 10 - 07
7
2021 - 10 - 04
8
2021 - 09 - 29
7
2021 - 09 - 28
7
2021 - 09 - 27
11
2021 - 09 - 20
13
2021 - 09 - 17
10
2021 - 09 - 16
9
2021 - 09 - 13
12
2021 - 06 - 29
7
2021 - 06 - 28
7
2021 - 06 - 25
10
2021 - 06 - 11
9
2021 - 06 - 07
8
2021 - 05 - 24
7
2021 - 05 - 21
15
2021 - 05 - 20
8
2021 - 05 - 11
7
2021 - 04 - 12
7
2021 - 03 - 24
8
2021 - 03 - 15
7
2020 - 12 - 09
7
Sector
Commercial services
42
Communications
28
Construction
1
Consumer durables
6
Consumer non-durables
25
Consumer services
15
Distribution services
4
Electronic technology
47
Energy minerals
12
Finance
111
Finance and insurance
13
Health care and social assistance
8
Health services
22
Health technology
1944
Industrial services
17
Information
13
Manufacturing
212
Mining, quarrying, and oil and gas extraction
32
Miscellaneous
4
N/a
81
Non-energy minerals
93
Process industries
34
Producer manufacturing
44
Professional, scientific, and technical services
94
Real estate and rental and leasing
1
Retail trade
10
Technology services
72
Transportation
7
Transportation and warehousing
7
Utilities
8
Wholesale trade
1
Tags
Acquisition
7773
Agreement
3051
Application
2381
Approval
2332
Business
4458
Cancer
4276
Ceo
2613
Ces
2841
Collaboration
2372
Conference
23415
Corporation
5667
Covid
2539
Deadline
3243
Disease
2684
Distribution
2471
Drug
2773
Earnings
3666
Energy
7555
Europe
2399
Events
4811
Fda
3595
Financial
16109
Financial results
7597
Global
11773
Group
5167
Growth
12806
Health
5039
International
2436
Management
2803
Market
24457
Media
2242
Meeting
3615
N/a
281661
Nasdaq
3868
Offering
7158
Partnership
2834
People
2345
Pharma
2416
Pharmaceuticals
3027
Platform
2393
Positive
3027
Presentation
2950
Program
3926
Report
15928
Research
10636
Results
41550
Sales
2230
Services
3093
Solutions
2813
Spac
2406
Study
2662
System
2704
Technology
6604
Test
2257
Therapeutics
9565
Therapy
2861
Treatment
5293
Trial
6814
Update
5248
Year
7787
Entities
Abbvie inc.
30
Adial pharmaceuticals, inc
10
Alnylam pharmaceuticals, inc.
19
Amgen inc.
14
Amplitude healthcare acquisition corp
9
Annovis bio, inc.
10
Aquestive therapeutics, inc.
18
Arrival
21
Astellas pharma inc
14
Astrazeneca plc
13
Beigene, ltd.
19
Beyondspring, inc.
11
Biogen inc.
13
Biontech se
17
Bridgebio pharma, inc.
16
Bristol-myers squibb company
27
Celldex therapeutics, inc.
10
Clearside biomedical, inc.
15
Coherus biosciences, inc.
21
Dare bioscience, inc.
13
Eli lilly and company
30
Equillium, inc.
9
Fortress biotech, inc.
10
Gartner, inc.
12
Gilead sciences, inc.
13
Glaxosmithkline plc
12
Halozyme therapeutics, inc.
9
Hoth therapeutics, inc.
14
I-mab
9
Immix biopharma, inc.
10
Immutep limited
11
Incyte corporation
15
Ionis pharmaceuticals, inc.
21
Johnson & johnson
46
Kering
11
Lithium corp
14
Mediwound ltd.
11
Merck & company, inc.
19
Morgan stanley
10
Myovant sciences ltd.
10
Nasdaq, inc.
42
Novartis ag
19
Orange
21
Pfizer, inc.
45
Pliant therapeutics, inc.
10
Redhill biopharma ltd.
10
Regeneron pharmaceuticals, inc.
26
Regenxbio inc.
17
Rocket pharmaceuticals, inc.
11
Sanofi
103
Scynexis, inc.
11
Sellas life sciences group, inc.
11
Sorrento therapeutics, inc.
19
Takeda pharmaceutical company limited
14
Taylor devices, inc.
17
Teva pharmaceutical industries ltd
14
Tonix pharmaceuticals holding corp.
12
Transcode therapeutics inc
10
Vertex pharmaceuticals incorporated
11
Veru inc.
10
Symbols
ABBV
30
ADIL
10
ALNY
19
ALPMF
14
ALPMY
14
AMGN
14
ANVS
10
AQST
18
ARVL
21
AZN
13
BBIO
16
BGNE
19
BIIB
13
BMY
27
BNTX
17
BYSI
11
CHRS
21
CLDX
10
CLSD
15
DARE
13
FBIO
10
FNCTF
21
GILD
13
GSK
12
HOTH
14
IMMP
11
IMMX
10
INCY
15
IONS
21
IT
12
JNJ
46
LLY
30
LTUM
14
MDWD
11
MRK
19
MS
10
MYOV
10
NDAQ
42
NVS
19
NVSEF
15
PFE
45
PLRX
10
PPRUF
11
PPRUY
11
RCKT
11
RDHL
10
REGN
26
RGNX
17
RNAZ
10
SCYX
11
SLS
11
SNY
103
SNYNF
79
SRNE
19
TAK
14
TAYD
17
TEVJF
14
TNXP
12
VERU
10
VRTX
11
Exchanges
Amex
87
Nasdaq
2561
Nyse
531
Crawled Date
2023 - 12 - 18
10
2023 - 12 - 13
8
2023 - 12 - 12
11
2023 - 12 - 11
13
2023 - 11 - 03
10
2023 - 11 - 02
8
2023 - 10 - 30
8
2023 - 10 - 16
10
2023 - 09 - 26
10
2023 - 09 - 07
8
2023 - 07 - 17
12
2023 - 06 - 05
13
2023 - 05 - 25
10
2023 - 05 - 16
11
2023 - 05 - 09
9
2023 - 04 - 26
10
2023 - 04 - 17
8
2023 - 03 - 28
8
2023 - 02 - 16
8
2022 - 11 - 03
10
2022 - 09 - 16
9
2022 - 07 - 28
8
2022 - 06 - 22
9
2022 - 06 - 10
9
2022 - 05 - 23
8
2022 - 04 - 25
8
2022 - 02 - 25
9
2022 - 02 - 14
10
2021 - 12 - 13
19
2021 - 12 - 09
15
2021 - 12 - 06
8
2021 - 11 - 30
8
2021 - 11 - 29
12
2021 - 11 - 15
9
2021 - 11 - 12
12
2021 - 11 - 08
8
2021 - 10 - 25
8
2021 - 10 - 15
9
2021 - 10 - 04
8
2021 - 09 - 29
7
2021 - 09 - 28
7
2021 - 09 - 27
11
2021 - 09 - 20
13
2021 - 09 - 17
10
2021 - 09 - 16
9
2021 - 09 - 13
12
2021 - 06 - 29
7
2021 - 06 - 28
7
2021 - 06 - 25
10
2021 - 06 - 11
9
2021 - 06 - 07
8
2021 - 05 - 24
7
2021 - 05 - 21
15
2021 - 05 - 20
8
2021 - 05 - 11
7
2021 - 03 - 24
8
2021 - 03 - 15
7
2020 - 12 - 11
8
2020 - 12 - 09
7
2020 - 12 - 01
10
Crawled Time
00:00
49
00:20
10
01:00
25
02:00
14
03:00
7
04:00
6
04:20
2
05:00
15
06:00
32
07:00
46
08:00
40
08:20
7
09:00
38
10:00
35
11:00
221
11:01
3
11:03
2
12:00
463
12:01
5
12:03
8
12:04
2
12:07
2
12:15
41
12:20
100
12:30
65
12:58
2
13:00
311
13:01
5
13:02
3
13:05
2
13:07
2
13:14
2
13:15
30
13:20
65
13:30
67
13:35
2
14:00
200
14:01
9
14:15
20
14:20
34
14:30
37
15:00
117
15:15
7
15:20
14
15:30
30
16:00
69
16:01
3
16:20
35
17:00
94
18:00
67
19:00
48
20:00
97
20:20
22
21:00
117
21:06
5
22:00
114
22:01
3
22:12
3
22:13
5
23:00
80
Source
adnas.com
2
alteritytherapeutics.com
1
alzamend.com
2
americann.co
1
arcutis.com
1
beamforall.com
1
bridgebio.com
3
brightmindsbio.com
1
encoreenergycorp.com
1
hightideinc.com
2
immunitybio.com
1
investor.aveooncology.com
1
investors.biomarin.com
1
investors.phiopharma.com
2
ionispharma.com
1
ir.akerotx.com
3
ir.anaptysbio.com
4
ir.auriniapharma.com
1
ir.benitec.com
2
ir.biolase.com
1
ir.biolinerx.com
2
ir.cyclerion.com
4
ir.hoththerapeutics.com
4
ir.kalvista.com
1
ir.opgen.com
1
ir.stockpr.com
2
ir.viveve.com
1
ir.vtvtherapeutics.com
2
ir.zynerba.com
1
mindmed.co
2
nanthealth.com
1
neurosense.investorroom.com
5
piedmontlithium.com
1
renovorx.com
2
revivapharma.com
1
sixthwave.com
1
spacfeed.com
9
www.4dpharmaplc.com
5
www.adnas.com
2
www.aquestive.com
7
www.avrupaminerals.com
2
www.beyondspringpharma.com
4
www.biospace.com
1138
www.cecorp.ca
2
www.cumulusmedia.com
2
www.curevac.com
2
www.cxxi.ca
3
www.eyenoviabio.com
2
www.globenewswire.com
1224
www.hancockjaffe.com
3
www.hubspot.com
4
www.inventivapharma.com
2
www.izea.com
2
www.lomiko.com
2
www.pensaregrp.com
2
www.prnewswire.com
477
www.rangerenergy.com
6
www.taylordevices.com
17
www.vbivaccines.com
3
www.vynetherapeutics.com
5
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Positive
save search
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
Published:
2024-04-08
(Crawled : 11:00)
- globenewswire.com
INZY
|
$4.65
-4.12%
-4.3%
410K
|
Health Technology
|
-26.89%
|
O:
2.2%
H:
7.69%
C:
-9.69%
inz-701
pharma
positive
ongoing
trials
topline
Syndax Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session
Published:
2024-04-08
(Crawled : 11:00)
- prnewswire.com
SNDX
|
$20.75
-2.49%
-2.55%
1.7M
|
Health Technology
|
-7.29%
|
O:
3.35%
H:
0.0%
C:
-1.34%
gment-101
positive
leukemia
trial
Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Published:
2024-04-08
(Crawled : 11:00)
- biospace.com/
OCS
6 d
|
$11.9
-0.83%
-0.08%
33K
|
n/a
|
6.34%
|
O:
0.36%
H:
0.18%
C:
-2.76%
ocs-01
positive
treatment
for
meeting
trial
results
Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome
Published:
2024-04-07
(Crawled : 16:20)
- prnewswire.com
IONS
|
$40.91
-1.52%
-1.49%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
positive
for
results
study
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
Published:
2024-04-06
(Crawled : 16:20)
- globenewswire.com
OCUL
|
$7.58
-2.7%
-2.77%
980K
|
Health Technology
|
Email alert
Add to watchlist
glaucoma
ocular
positive
meeting
Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
Published:
2024-04-05
(Crawled : 12:30)
- biospace.com/
NTRA
|
$90.33
0.01%
0.01%
690K
|
Health Services
|
-2.51%
|
O:
2.12%
H:
4.35%
C:
2.25%
bladder
positive
cancer
trial
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
Published:
2024-04-05
(Crawled : 12:00)
- globenewswire.com
TARA
|
$2.75
-3.51%
-3.64%
170K
|
Health Technology
|
-32.09%
|
O:
16.92%
H:
11.06%
C:
-22.77%
tara-002
positive
program
therapeutics
Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410—a Modifier Gene Therapy—in Phase 1/2 ArMaDa Study for Geographic Atrophy
Published:
2024-04-05
(Crawled : 11:00)
- globenewswire.com
OCGN
|
News
A
|
$1.44
-9.43%
-10.42%
6.9M
|
Health Technology
|
0.0%
|
O:
1.92%
H:
0.0%
C:
0.0%
ocu410
armada
review
positive
for
study
Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
Published:
2024-04-04
(Crawled : 12:00)
- globenewswire.com
TPST
|
$3.26
-2.69%
-2.76%
350K
|
Manufacturing
|
-31.45%
|
O:
8.39%
H:
2.71%
C:
-12.96%
tpst-1120
tumors
positive
cancer
publication
research
communications
trial
advanced
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap™ Platform Development
Published:
2024-04-04
(Crawled : 12:00)
- globenewswire.com
BIOR
|
$0.6421
3.4%
2.98%
320K
|
Health Care and Social Assistan...
|
-16.09%
|
O:
1.34%
H:
0.0%
C:
-4.21%
bt-600
positive
trial
therapeutics
results
platform
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
Published:
2024-04-04
(Crawled : 12:00)
- globenewswire.com
CADL
|
$5.44
-7.64%
-8.57%
820K
|
|
268.12%
|
O:
26.87%
H:
276.85%
C:
215.27%
can-2409
positive
cancer
pancreatic
trial
therapeutics
Mirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution) Receives Positive Reimbursement Recommendation by Canada’s CADTH for Patients with Cholestatic Pruritus in Alagille Syndrome
Published:
2024-04-02
(Crawled : 22:00)
- biospace.com/
MIRM
|
$23.85
-0.67%
-0.59%
330K
|
Health Technology
|
-6.29%
|
O:
-1.3%
H:
0.7%
C:
0.36%
pruritus
positive
livmarli
CYduct Diagnostics Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer
Published:
2024-04-02
(Crawled : 14:30)
- biospace.com/
CYDX
|
$0.41
-14.15%
290
|
n/a
|
Email alert
Add to watchlist
breast
biomarker
positive
cancer
diagnostics
results
study
Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status
Published:
2024-04-02
(Crawled : 14:30)
- biospace.com/
PTPI
|
$0.689
-2.27%
-2.32%
460K
|
|
Email alert
Add to watchlist
positive
pharmaceuticals
results
study
C-Bond Systems Reports 2023 Highlights Including Record Revenue and Positive Net Income; Company to Host Conference Call on April 3rd
Published:
2024-04-02
(Crawled : 12:30)
- globenewswire.com
CBNT
|
$0.0042
7.69%
122.22%
950K
|
Manufacturing
|
-9.3%
|
O:
-11.63%
H:
7.89%
C:
7.89%
conference
company
revenue
positive
Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System
Published:
2024-04-02
(Crawled : 12:30)
- prnewswire.com
GNPX
|
$2.21
-3.91%
-1.77%
21K
|
Health Technology
|
-25.59%
|
O:
-5.72%
H:
7.14%
C:
1.43%
oncoprex
positive
system
preclinical
therapy
Roivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 Million
Published:
2024-04-02
(Crawled : 11:00)
- globenewswire.com
ROIV
|
$10.45
-2.43%
-2.49%
4M
|
Manufacturing
|
0.1%
|
O:
4.79%
H:
3.02%
C:
-0.09%
pharma
million
authorization
positive
repurchase
results
study
Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410ST—a Modifier Gene Therapy—in GARDian Study for Stargardt Disease
Published:
2024-04-01
(Crawled : 22:00)
- globenewswire.com
OCGN
|
News
A
|
$1.44
-9.43%
-10.42%
6.9M
|
Health Technology
|
-2.5%
|
O:
-10.0%
H:
0.69%
C:
-4.17%
ocu410
disease
review
positive
study
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
Published:
2024-04-01
(Crawled : 20:00)
- globenewswire.com
GRTS
|
$0.7452
-3.46%
-3.64%
3M
|
Health Technology
|
-70.36%
|
O:
-48.62%
H:
5.38%
C:
-7.69%
positive
cancer
ongoing
tumor
dna
study
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
Published:
2024-04-01
(Crawled : 19:00)
- biospace.com/
EQ
|
$1.79
-3.24%
0.0%
93K
|
Health Technology
|
-19.91%
|
O:
-1.73%
H:
0.0%
C:
-7.05%
lupus
positive
topline
study
← Previous
1
2
3
4
5
6
7
8
9
…
151
152
Next →
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.82
139.47%
56.82%
220M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.66
46.37%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
600K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.3442
18.28%
23.42%
290K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.